Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-01 · accession 0001193125-26-088260 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-03-01 | NTLA | BASTA JAMES | EVP, GC | A - Grant | $0.00 | +46.1K | 158.0K | +41% | $0 |
| D | 2026-03-03 | 2026-03-02 | NTLA | BASTA JAMES | EVP, GC | S - Sale | $13.78 | -1,211 | 156.8K | -0.8% | -$16.7K |
| D | 2026-03-03 | 2026-03-01 | NTLA | BASTA JAMES | EVP, GC | A - Grant | $0.00 | +65.8K | 65.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-01 | A | A | 46,080 | $0.00 | 158,005 | D | — | — | (F1) Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit |
| 2 | Common | Common Stock | 2026-03-02 | S | D | 1,211 | $13.78 | 156,794 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2026-03-01 | A | A | 65,829 | $0.00 | 65,829 | D | $13.78 · — to 2036-02-29 | 65,829 Common Stock | (F3) This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter. |